NEW YORK (GenomeWeb) – Qiagen today announced it has acquired bioinformatics firm OmicSoft for an undisclosed amount of cash.

OmicSoft markets a suite of tools that allow researchers to analyze and visualize data and compare them to large, publicly available multi-omics data sets. Qiagen said the acquisition will provide it with scalable and flexible software architecture solutions that will enable it to expand its bioinformatics offerings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.